[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Veradermics Incorporated (MANE)

Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks Slip as Higher Oil Prices Spur Inflation Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -0.12%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.30%. June E-mini S&P futures...

ALK : 40.94 (-1.56%)
UAL : 91.75 (-1.34%)
AMAT : 401.18 (-3.80%)
SNDK : 1,063.19 (+7.40%)
VZ : 47.51 (+2.44%)
ADI : 388.04 (-2.89%)
TXN : 269.06 (-2.92%)
$IUXX : 27,251.10 (-0.19%)
DPZ : 333.11 (-9.44%)
ZNM26 : 110-305 (-0.24%)
ESM26 : 7,198.25 (+0.05%)
NCLH : 18.33 (-0.97%)
Stocks Pressured by Higher Oil Prices

The S&P 500 Index ($SPX ) (SPY ) today is unchanged, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.10%. June E-mini S&P futures (ESM26...

AAPL : 267.04 (-1.48%)
CRWD : 456.63 (+1.90%)
VZ : 47.51 (+2.44%)
$SPX : 7,164.23 (-0.01%)
MU : 520.86 (+4.86%)
MANE : 91.07 (+34.24%)
$IUXX : 27,251.10 (-0.19%)
NQM26 : 27,399.75 (-0.13%)
DPZ : 333.11 (-9.44%)
QQQ : 664.00 (+0.02%)
CLM26 : 97.14 (+2.90%)
ZNM26 : 110-305 (-0.24%)
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss

VDPHL01, a novel orally-administered extended-release minoxidil formulation, met all primary and all key secondary endpoints with high statistical significance in both active treatment arms evaluating...

MANE : 91.07 (+34.24%)
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss

Conference call will take place on Monday, April 27, 2026 at 8:00 am ET

MANE : 91.07 (+34.24%)
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates

Enrollment completed in two pivotal trials of VDPHL01 in male patients; topline data expected from Study 302 in 1H 2026 and Study 304 confirmatory trial in 2H 2026 Enrollment...

MANE : 91.07 (+34.24%)
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological conditions,...

MANE : 91.07 (+34.24%)
Veradermics to Participate in Upcoming March Investor Conferences

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological conditions,...

MANE : 91.07 (+34.24%)
Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss

This marks the completion of enrollment of all male Phase 3 studies of VDPHL01 in pattern hair loss, with approximately 1,000 male patients enrolled across studies ...

MANE : 91.07 (+34.24%)
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

Veradermics, Incorporated (“Veradermics”), (NYSE: MANE) a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and...

MANE : 91.07 (+34.24%)
Veradermics Announces Pricing of Upsized Initial Public Offering

Veradermics, Incorporated (“Veradermics”), (NYSE: MANE) a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and...

MANE : 91.07 (+34.24%)

Barchart Exclusives

Micron Stock Keeps Soaring, as Investors Make Unusually Heavy MU Option Trades
Micron stock is up again over 5% today, and unusual options activity is seen in a Barchart report. Analysts keep raising their revenue and price targets over the next two years. MU stock could still be 18% undervalued. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.